Quarterly report pursuant to Section 13 or 15(d)

Sharebased Compensation (Details Narrative)

v3.23.2
Sharebased Compensation (Details Narrative) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended 9 Months Ended
Jun. 30, 2023
Sep. 30, 2022
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Stock options available to be granted under amended plan       4,787,000  
Restricted Stock options available to be granted under amended plan       4,098,000  
Directors and officers [Member]          
Restricted shares granted based on fiscal 2022 performance       551,000  
2013 Incentive Stock Plan [Member]          
Shares authorized to be granted under amended plan       15,000,000  
Restricted stock available to be granted under amended Plan       7,500,000  
Stock option available to be granted under amended Plan       7,500,000  
Restricted common stock shares granted under amendment plan       760,000  
Restricted stock and stock options available to be granted under amended plan       8,885,000  
Increased restricted stock and stock option grants under amended plan       10,000,000  
Stock Option [Member]          
Stock options granted under amended plan       524,000  
Warrants [Member] | Stock Option [Member]          
Restricted Stock options available to be granted under amended plan       435,000  
Share-based compensation expense $ 57   $ 93 $ 382 $ 244
Unrecognized compensation expense       $ 453  
Weighted average vesting period       3 years 9 months 14 days  
Warrant [Member]          
Weighted average remaining contractual life   2 years 6 months   1 year 9 months 3 days  
Weighted average exercise price per share   $ 2   $ 2  
Warrants outstanding   77,000   77,000  
Restricted Stock [Member]          
Share-based compensation expense $ 119   $ 76 $ 294 $ 224
Unrecognized compensation expense       $ 610  
Weighted average vesting period       3 years 21 days